Page 206 - Cellular Imaging in Regenerative Medicine, Cancer and Osteoarthritis

Chapter 11
Joost Haeck, Karin Bol, Sander Bison, Sandra van Tiel, Stuart Koelewijn, Marion de Jong, Jifke Veenland and Monique Bernsen. Optimized time-resolved imaging of contrast kinetics (TRICKS) in dynamic contrast-enhanced MRI after peptide receptor radionuclide therapy in small animal tumor models. Contrast Media Mol Imaging. 2015 May 21
Ten Hagen TL, Seynhaeve AL, de Wiel-Ambagtsheer Ga, de Bruijn EA, van Tiel ST, Ruegg C, Meyring M, Grell M, Goodman SL, Eggermont AM. The αVβ3/αVβ5 integrin inhibitor cilengitide augments tumor response to melphalan isolated limb perfusion in a sarcoma model. Int J Cancer. 2013 Jun 1;132(11):2694-704
Kotek G, van Tiel ST, Wielopolski PA, Houston GC, Krestin GP, Bernsen MR. Cell quantification: evolution of compartmentalization and distribution of iron-oxide particles and labeled cells. Contrast Media Mol Imaging. 2012 Mar- Apr;7(2):195-203
Alic L, Haeck JC, Bol K, Klein S, van Tiel ST, Wielopolski PA, de Jong M, Niessen WJ, Bernsen M, Veenland JF. Facilitating tumor functional assessment by spatially relating 3D tumor histology and in vivo MRI: image registration approach. PLoS One. 2011; 6(8):e22835
van Tiel ST, Wielopolski PA, Houston GC, Krestin GP, Bernsen MR. Variations in labeling protocol influence incorporation, distribution and retention of iron oxide nanoparticles into human umbilical vein endothelial cells. Contrast Media Mol Imaging. 2010 Sep-Oct;5(5):247-57.
van Buul GM, Farrell E, Kops N, van Tiel ST, Bos PK, Weinans H, Krestin GP, van Osch GJ, Bernsen MR. Ferumoxides-protamine sulfate is more effective than ferucarbotran for cell labeling: implications for clinically applicable cell tracking using MRI. Contrast Media Mol Imaging. 2009 Sep; 4(5):230-6.
Bernsen MR, Moelker AD, Wielopolski PA, van Tiel ST, Krestin GP. Labelling of mammalian cells for visualisation by MRI. Eur Radiol. 2009 Aug 12.
Farrell E, Wielopolski P, Pavljasevic P, van Tiel S, Jahr H, Verhaar J, Weinans H, Krestin G, O’Brien FJ, van Osch G, Bernsen M. Effects of iron oxide incorporation
204